Gyroscope Therapeutics Funding: $148M Raised, Series C
Gyroscope Therapeutics is based in London, United Kingdom. It has raised $148M in total funding. Latest round: Series C.
Gyroscope Therapeutics funding overview
Gyroscope Therapeutics is based in London, United Kingdom. Gyroscope Therapeutics has raised $148M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2021. The round record for Gyroscope Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Forbion’s Growth Opportunities Fund, Sofinnova Investments, T. Rowe Price Associates, Inc., Tetragon Financial Group Limited, Fosun Pharma, Cambridge Innovation Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Gyroscope Therapeutics funding
How much has Gyroscope Therapeutics raised?
Gyroscope Therapeutics has raised $148M in total disclosed funding across the rounds on record.
Who has invested in Gyroscope Therapeutics?
Forbion’s Growth Opportunities Fund, Sofinnova Investments, T. Rowe Price Associates, Inc., Tetragon Financial Group Limited, Fosun Pharma, Cambridge Innovation Capital are named among the investors backing Gyroscope Therapeutics.
What was the latest Gyroscope Therapeutics funding round?
The most recent disclosed round is a Series C, announced in March 2021.
Where is Gyroscope Therapeutics based?
Gyroscope Therapeutics is based in London, United Kingdom.
When did Gyroscope Therapeutics last raise?
The last disclosed Gyroscope Therapeutics round closed in March 2021 at Series C.
Round data for Gyroscope Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in London and backer lists below.
